We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · December 07, 2020

Adjuvant Chemotherapy Is Superior to Chemoradiation After D2 Surgery for Gastric Cancer

Annals of Oncology

 

Additional Info

Annals of Oncology
Adjuvant Chemotherapy Is Superior to Chemoradiation After D2 Surgery for Gastric Cancer in the Per-Protocol Analysis of the Randomized CRITICS Trial
Ann. Oncol 2020 Nov 20;[EPub Ahead of Print], WO de Steur, RM van Amelsfoort, HH Hartgrink, H Putter, E Meershoek-Klein Kranenbarg, NCT van Grieken, JW van Sandick, YHM Claassen, JPBM Braak, EPM Jansen, K Sikorska, H van Tinteren, I Walraven, P Lind, M Nordsmark, MI van Berge Henegouwen, HWM van Laarhoven, A Cats, M Verheij, CJH van de Velde

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading